New technique was developed for reconstruction of airway following surgery can benefit many patients with lung cancer and end-stage tracheobronchial disease.

‘Airway replacement using a cryopreserved aortic graft and the custom-made stent can benefit many patients with lung cancer and end-stage tracheobronchial disease.’

The study included 20 patients with lung tumors or tracheal lesions, of which 13 patients had diseased airway sections removed and underwent airway transplantation (5 tracheal, 7 bronchial and 1 carinal, which is where the trachea divides into the bronchi of the lungs); study conducted from October 2009 through February 2017, with final patient follow-up in November 2017.




Airway transplantation using a cryopreserved aortic graft and a custom-made stent inserted into the graft to keep the airway from collapsing but was later removed (exposure); 90-day morality (primary outcome).
This was a cohort study where people were followed over time.
The authors of the study were Emmanuel Martinod, M.D., Ph.D., Assistance Publique-Hopitaux de Paris, Bobigny, France, and coauthors.
The results of the study show
- Overall 90-day mortality among initial 20 patients was 5% because one patient who underwent carinal transplantation died
- No deaths after 90 days among patients who underwent tracheal or bronchial reconstruction
- About 10 of 13 patients who underwent transplantation alive after nearly four years
- Nearly 8 of 10 breathing normally through newly formed airways after stent removal
- New generation of cartilage was observed in transplanted areas The study limitations are limited number of patients in this feasibility study at a single center without a comparison group; larger studies needed to further assess effectiveness and safety.
Advertisements
Source-Eurekalert